Events

A novel microbiome-derived peptide, SG-3-00802 reverses resistance to anti-programmed cell death protein-1 (PD-1) therapy by modulating chemokine receptor signaling [Encore Presentation]

Presentation

Targeting the CXCR3 pathway with a novel peptide drug candidate mobilizes the immune system to enhance anti-tumor immunity

Virtual KOL Panel

SG-5-00455 and the Role of Mucosal Healing and PAI-1/2 in IBD

Presentation

Identification and development of a 1st in class naturally-derived protein that drives mucosal healing and is orally delivered by an engineered cellular therapy targeting the gastro-intestinal tract

Presentation

1st In Class Naturally Derived Protein That Directly Improves Mucosal Healing and is Delivered Directly to the Gut by an Engineered Lactococcus lactis Expression System

Presentation

1st In Class Naturally Derived Protein That Directly Improves Mucosal Healing Delivered Directly to the Gut by an Engineered Lactococcus lactis Expression System

Presentation

A novel microbiome-derived peptide, SG-3-00802 reverses resistance to anti-programmed cell death protein-1 (PD-1) therapy by modulating chemokine receptor signaling

Poster

Strain-level meta-analysis of Parkinson’s disease-associated gut microbiome

Poster

Predicted Metabolites from Multiple Microbiome Sequencing Datasets Modulate Autism Spectrum Phenotype in Mice

Talk

Lightweight Multi-Tenancy with Django Guardian